• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

10号染色体长臂上D10S170与RET并列并产生致癌序列RET/PTC的倒位特征分析

Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.

作者信息

Pierotti M A, Santoro M, Jenkins R B, Sozzi G, Bongarzone I, Grieco M, Monzini N, Miozzo M, Herrmann M A, Fusco A

机构信息

Divisione di Oncologia Sperimentale A, Istituto Nazionale Tumori, Milan, Italy.

出版信息

Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1616-20. doi: 10.1073/pnas.89.5.1616.

DOI:10.1073/pnas.89.5.1616
PMID:1542652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC48503/
Abstract

RET/PTC is a transforming sequence created by the fusion of the tyrosine kinase domain of the RET protooncogene with the 5' end of the locus D10S170 designated by probe H4 and is frequently found activated in human papillary thyroid carcinomas. RET and D10S170 have been mapped to contiguous regions of the long arm of chromosome 10: q11.2 and q21, respectively. To identify the mechanism leading to the generation of the oncogenic sequence RET/PTC, a combined cytogenetic and molecular analysis of several cases of papillary thyroid carcinomas was done. In four cases the results indicated that these tumors had RET/PTC activation and a paracentric inversion of the long arm of chromosome 10, inv(10)(q11.2q21), with breakpoints coincident with the regions where RET and D10S170 are located. Therefore, a chromosome 10q inversion provides the structural basis for the D10S170-RET fusion that forms the hybrid transforming sequence RET/PTC.

摘要

RET/PTC是一种由RET原癌基因的酪氨酸激酶结构域与探针H4指定的基因座D10S170的5'端融合而产生的转化序列,在人类甲状腺乳头状癌中经常被发现激活。RET和D10S170分别定位于10号染色体长臂的相邻区域:q11.2和q21。为了确定导致致癌序列RET/PTC产生的机制,对几例甲状腺乳头状癌进行了细胞遗传学和分子联合分析。在四例病例中,结果表明这些肿瘤具有RET/PTC激活以及10号染色体长臂的臂间倒位,inv(10)(q11.2q21),断点与RET和D10S170所在区域一致。因此,10号染色体q臂倒位为形成杂交转化序列RET/PTC的D10S170-RET融合提供了结构基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/2717ac564abd/pnas01079-0111-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/49d02feb0f8e/pnas01079-0109-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/e0ed658e580c/pnas01079-0110-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/8e0d7a1d86a9/pnas01079-0111-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/cce22f73906b/pnas01079-0111-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/09f51f9ce079/pnas01079-0111-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/2717ac564abd/pnas01079-0111-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/49d02feb0f8e/pnas01079-0109-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/e0ed658e580c/pnas01079-0110-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/8e0d7a1d86a9/pnas01079-0111-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/cce22f73906b/pnas01079-0111-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/09f51f9ce079/pnas01079-0111-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/48503/2717ac564abd/pnas01079-0111-d.jpg

相似文献

1
Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.10号染色体长臂上D10S170与RET并列并产生致癌序列RET/PTC的倒位特征分析
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1616-20. doi: 10.1073/pnas.89.5.1616.
2
Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.由ret酪氨酸激酶与环磷酸腺苷依赖性蛋白激酶A的调节亚基RIα融合形成的甲状腺肿瘤特异性转化序列的分子特征
Mol Cell Biol. 1993 Jan;13(1):358-66. doi: 10.1128/mcb.13.1.358-366.1993.
3
A novel multicolor hybridization scheme applied to localization of a transcribed sequence (D10S170/H4) and deletion mapping in the thyroid cancer cell line TPC-1.
Cytogenet Cell Genet. 1996;75(4):254-7. doi: 10.1159/000134495.
4
RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.通过间期荧光原位杂交检测甲状腺乳头状癌和腺瘤中的RET重排。
Cytogenet Cell Genet. 2000;88(1-2):56-61. doi: 10.1159/000015485.
5
Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.人甲状腺乳头状癌中ret/PTC癌基因的断点特征分析
Hum Mol Genet. 1995 Dec;4(12):2313-8. doi: 10.1093/hmg/4.12.2313.
6
Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC.
Oncogene. 1991 Feb;6(2):339-42.
7
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.RET/PTC3的分子特征;人类甲状腺乳头状癌中RET原癌基因的一种新的重排形式
Oncogene. 1994 Feb;9(2):509-16.
8
A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma.
Genes Chromosomes Cancer. 1994 Apr;9(4):244-50. doi: 10.1002/gcc.2870090404.
9
H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization.H4(D10S170),一种在甲状腺乳头状癌中常与RET基因重排的基因:功能特征
Oncogene. 2004 Jan 8;23(1):109-21. doi: 10.1038/sj.onc.1206981.
10
RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.辐射诱导的甲状腺乳头状癌中的RET重排:断点处拓扑异构酶I位点的高发生率以及ELE1和RET嵌合基因中的微同源性介导的末端连接
Genomics. 2001 Apr 15;73(2):149-60. doi: 10.1006/geno.2000.6434.

引用本文的文献

1
Identification and Characterization of a Novel Gene Rearrangement in an Advanced Colorectal Cancer Patient: A Case Report.一名晚期结直肠癌患者中一种新型基因重排的鉴定与特征分析:病例报告
Int J Mol Sci. 2024 Nov 26;25(23):12665. doi: 10.3390/ijms252312665.
2
A post-irradiation-induced replication stress promotes RET proto-oncogene breakage.辐照诱导的复制应激促进 RET 原癌基因断裂。
Eur Thyroid J. 2024 Aug 23;13(4). doi: 10.1530/ETJ-24-0028. Print 2024 Aug 1.
3
activity is required to prevent mitotic arrest, spindle assembly checkpoint activation and lethality in glioblastoma and other cancers.

本文引用的文献

1
Molecular cloning of a new transforming gene from a chemically transformed human cell line.从化学转化的人细胞系中克隆一个新的转化基因
Nature. 1984;311(5981):29-33. doi: 10.1038/311029a0.
2
Differential expression of the normal and of the translocated human c-myc oncogenes in B cells.正常与易位的人类c-myc癌基因在B细胞中的差异表达。
Proc Natl Acad Sci U S A. 1983 Aug;80(15):4822-6. doi: 10.1073/pnas.80.15.4822.
3
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases.人类甲状腺乳头状癌及其淋巴结转移灶中的一种新致癌基因。
需要活性来防止胶质母细胞瘤和其他癌症中的有丝分裂停滞、纺锤体组装检查点激活和致死性。
NAR Cancer. 2024 May 20;6(2):zcae021. doi: 10.1093/narcan/zcae021. eCollection 2024 Jun.
4
High expression of CCDC6 in relation to unfavorable outcome and immune cells infiltration in hepatobiliary carcinoma.CCDC6在肝胆癌中的高表达与不良预后及免疫细胞浸润的关系
J Cancer. 2022 Sep 21;13(12):3378-3395. doi: 10.7150/jca.76050. eCollection 2022.
5
Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing.基于下一代测序的中国多癌回顾性分析中 RET 融合的鉴定。
Cancer Sci. 2022 Jan;113(1):308-318. doi: 10.1111/cas.15181. Epub 2021 Nov 15.
6
Fusion Genes and RNAs in Cancer Development.癌症发展中的融合基因与RNA
Noncoding RNA. 2021 Feb 4;7(1):10. doi: 10.3390/ncrna7010010.
7
A Performance Comparison of Commonly Used Assays to Detect RET Fusions.常用检测 RET 融合的方法的性能比较。
Clin Cancer Res. 2021 Mar 1;27(5):1316-1328. doi: 10.1158/1078-0432.CCR-20-3208. Epub 2020 Dec 3.
8
RET Gene Fusions in Malignancies of the Thyroid and Other Tissues.RET 基因融合在甲状腺和其他组织恶性肿瘤中的作用。
Genes (Basel). 2020 Apr 15;11(4):424. doi: 10.3390/genes11040424.
9
A novel read-through transcript JMJD7-PLA2G4B regulates head and neck squamous cell carcinoma cell proliferation and survival.一种新型通读转录本JMJD7-PLA2G4B调节头颈部鳞状细胞癌细胞的增殖和存活。
Oncotarget. 2017 Jan 10;8(2):1972-1982. doi: 10.18632/oncotarget.14081.
10
The emerging complexity of gene fusions in cancer.癌症中基因融合的新兴复杂性。
Nat Rev Cancer. 2015 Jun;15(6):371-81. doi: 10.1038/nrc3947.
Nature. 1987;328(6126):170-2. doi: 10.1038/328170a0.
4
Developmentally regulated expression of a human "finger"-containing gene encoded by the 5' half of the ret transforming gene.由ret转化基因5' 端编码的含人类“指状”基因的发育调控表达。
Mol Cell Biol. 1988 Apr;8(4):1853-6. doi: 10.1128/mcb.8.4.1853-1856.1988.
5
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.慢性髓性白血病中abl和bcr基因的融合转录本。
Nature. 1985;315(6020):550-4. doi: 10.1038/315550a0.
6
Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.bcl-2的cDNA克隆及结构分析,以及由t(14;18)易位产生的bcl-2/免疫球蛋白杂交转录本
Cell. 1986 Oct 10;47(1):19-28. doi: 10.1016/0092-8674(86)90362-4.
7
A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences.一种由截短的原肌球蛋白和蛋白酪氨酸激酶序列融合形成的人类癌基因。
Nature. 1986;319(6056):743-8. doi: 10.1038/319743a0.
8
Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing.ret-II癌基因的激活,该基因没有编码跨膜结构域的序列,以及由于可变剪接导致羧基末端不同的两种ret-II癌基因产物的转化活性。
Oncogene. 1989 Jun;4(6):789-94.
9
Human ret proto-oncogene mapped to chromosome 10q11.2.
Oncogene. 1989 Dec;4(12):1519-21.
10
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.人乳头状甲状腺癌中酪氨酸激酶癌基因的高频激活
Oncogene. 1989 Dec;4(12):1457-62.